Convalescent Plasma Reduces Mortality and Decreases Hospitalization Stay in Patients with Moderate COVID-19 Pneumonia

Humans infected with SARS-CoV-2 may develop COVID-19, which manifests across a wide spectrum of clinical severity ranging from mild upper respiratory tract illnesses to diffuse viral pneumonia, causing acute respiratory failure. Many therapies have been tested for their efficacy in treating COVID-19...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Maamoun Basheer, Elias Saad, Dorin Shlezinger, Nimer Assy
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
Accès en ligne:https://doaj.org/article/39c341d34bd845b8a70eddb50ac35c47
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!